|
Providence Hospital and Medical
Centers
May 2004 |
Monthly
Cystic Fibrosis Newsletter
Julie Feldman MPH RD, Clinical Dietitian |
|
|
|
|
|
|
Great
Strides
As the weather gets warmer, it is time to look for
your local Great Strides CF Foundation Fundraising Walk. This annual
event is held at thousands of locations nationwide and helps to contribute
a tremendous amount of money to CF research. Please help support
your local CF Foundation. Visit www.cff.org
for more information.
|
 |
|
|
|
|
|
|
 |
Water a
Cure
Researchers at UNC Chapel Hill believe the key to curing CF may be
water. It is thought that water is absorbed too readily by the lungs
of CF patients, leaving the lungs without enough lubricant to clear mucus
from the lungs. This allows mucus to build up and bacteria to
invade. By breeding mice with different types of CF dysfunction in
their lung, researchers were able to identify the malfunction that allows
salt and water to drain off airway surfaces three times faster than that
in normal lungs. This is the best working model of CF to date and
offers great hope for new research.
|
|
|
|
|
|
|
Milestone
Inologic
Inc. announced that it has reached its 2nd milestone in the development
of INO-4995 for the treatment of CF. This is a compound that restores
the chloride and sodium balance in lung tissues and consequently reduces
the buildup of thick mucus. The drug is delivered intranasaly and
offers great hope.
|
 |
|
|
|
|
|
|
 |
Enzyme Approval The CF Foundation announced its support of the FDA's requirement that
all manufacturers of pancreatic enzyme replacements must obtain FDA
approval for their product in the next four years. This is due to a
wide discrepancy in the amounts of active ingredients between enzyme
vendors. If you have a problem having your enzyme prescription
filled with a non-generic brand, please contact Dr. Pichurko's office for
assistance.
|
|
|
|
|
|
|
Inspire
Inspiring Inspire
pharmaceuticals Inc. announced excellent results from their Phase II
study of INS37217
Respiratory in patients with mild CF lung disease. The data will
be presented at the CF Conference in St. Louis in October. The results
after a four week trial showed statistically significant improvement in
lung function. This drug has been given Orphan Drug Status and Fast
Track designations from the FDA.
|
 |
|
|
|
|
|
 |
Pump up the Calories
Many of you are tired of the same old creamy
supplements. I wanted to make sure you were all aware of Source
Cookie Bars. There are two flavors of protein fortified nutritional
bars, packed with high energy calories. The recipes are formulated to
taste great with wholesome ingredients, while meeting the nutritional
needs of the CF patient.
Tipping the scales at a whopping 550 calories, the
chocolate chip Source Cookie Bar packs 20 grams of protein as well.
For more information visit http://www.sourcecf.com/nutritionals.htm
|
| All issues of Living
Your Best Life : |
May,
June,
Aug-Sept,
Oct,
Nov-Dec
2001
Jan,
Feb,
March,
April,
May,
Oct,
Nov
2002
Feb,
April,
May,
June,
Sept,
Oct,
Nov
2003
Jan,
Feb,
March,
April,
May,
Aug
2004
April, June,
July, Sept, Oct 2005
|
|